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Abstract
Silicosis,	a preventable	occupational	lung	disease,	is	associated	with	various	diseases,	including	tuberculosis	(TB).	There	is	an	
increased	lifelong	risk	for	lung	tuberculosis	even	if	exposure	to	silica	dust	ceases.	That	association	contributes	in	a large	extent	
to	very	high	rates	of	tuberculosis	in	countries	with	poor	TB	and	silica	exposure	control.	We	report	a case	of	a male	with	a prior	
diagnosis	of	silicosis	who	was	diagnosed	with	and	treated	for	TB.	Anti-tuberculous	treatment	was	extended	due	to	a positive	
sputum	smear	in	the	six	th	month	of	treatment.	However,	the	culture	of	the	sputum	was	negative.	This	case	report	highlights	the	
value	of	thorough	screening	for	tuberculosis	in	silicotic	patients.	The	clinical	management	of	these	patients	may	be	challenging	
due	to	frequent	overlapping	radiological	features	and	uncertain	results	of	TB	treatment.	
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Case report
Silicosis is a fibrotic lung disease resulting 
from exposure to silica dust. Worldwide, it is 
regarded as the most frequent occupational lung 
disorder. Although it is relatively rare in the 
developed countries, it is still fairly common in 
countries with poor occupational control such as 
the Republic of South Africa. It has been recog-
nized for years that there is a relationship between 
tuberculosis (TB) and silicosis. In fact, it has 
been reported that 25–30% of silicotic patients 
develop TB [1]. That adverse association is very 
common among workers in South Africa’s gold 
mining industry. The incidence of TB in South 
Africa is as high as 2707 per 100,000 in men with 
silicosis [1].
Given the fact that there is such a  strong 
relationship between TB and silicosis, we report 
a case of a male with predisposing silicosis and 
subsequent pulmonary TB.
A 58-year-old non-smoking male was admit-
ted to the tuberculosis ward with a history of a  
2 monthlong moderate cough with mucoid spu-
tum production, a monthlong fever (axillar tem-
perature up to 390C), night sweats, anorexia and 
loss of weight (8 kilos). He did not report any 
chest pain and hemoptysis. As an outpatient, he 
was treated with clarithromycin and ciprofloxaci-
lin with no significant clinical improvement. His 
medical history was remarkable for silicosis. It 
was diagnosed 15 years ago and since then he was 
regularly seen in the respiratory clinic. He used 
to work in an aluminium foundry for 17 years. 
Consequently, the long exposure to silica dust 
was recognized and the state benefit for silicosis 
as occupational disease was granted. He stopped 
smoking 30 years ago and rarely drank alcohol. 
He had no contact with a confirmed TB source. 
On examination, he was excessively kyphotic in 
cervical and thoracic region of the spine, visibly 
underweight (body-mass-index [BMI] 17 kg/
m2), slightly hypertensive (BP 150/90 mm Hg) 
and tachycardic (HR 100/min) with clear breath 
sounds on auscultation. On admission, his chest 
X-ray (CXR) (Fig. 1 A, B) showed multiple small 
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Figure 1 A, B.	Multiple	confluent	small	nodules	and	masses	in	the	upper	right	and	left	zones,	consolidation	in	the	middle	right	zone	and	small	right	
pleural	effusion
nodules in the upper right and left zones, consoli-
dation in the middle right zone and small right 
pleural effusion. Inflammatory markers were 
moderately raised (erythrocytes sedimentation 
rate — 68 mm/h, C-reactive protein 35 mg/L). His 
sputum smear was positive for acid-fast bacilli 
(AFB) (+++). Mycobacterium tuberculosis com-
plex was confirmed with GeneXpert MTB/RIF 
test. The strain was deemed rifampicin sensitive 
as no mutation was found in the rpoB gene. An-
ti-tuberculous treatment (ATT) was started with 
rifampicin (R), isoniazid (H), ethambutol (E) and 
pyrazinamide (Z) and piridoxine. Consequently, 
after 9 days, Mycobacterium tuberculosis was 
cultured and identified with MGIT (Mycobacte-
ria Growth Indicator Tube). Drug susceptibility 
testing (DST) showed sensitivity to all first-line 
drugs. At the beginning, the tolerance of ATT was 
poor with loss of appetite and an increase in liver 
function tests (LFT). The patient improved grad-
ually with resolution of cough and weight gain. 
His sputum samples were negative for AFB after 
2 months of ATT. Subsequently, after 2 months 
of in-hospital treatment he was discharged and 
treated as an outpatient with HR as a continuation 
phase for the next 4 months. He was admitted 
again in the 6th month of ATT due to the positive 
sputum smear (AFB +). On admission, he was 
well and reported nonfrequent cough and an 
increase in weight. The following sputum spec-
imens as well as bronchial washing were smear 
negative for AFB. ATT was continued with good 
tolerance while the cultures on liquid medium 
(MGIT) were monitored. Computed tomography 
(CT) of the chest revealed scattered calcified 
nodules in various sizes, irregular fibrotic mass 
with a central cavity in the right upper lobe as 
well as a thick-walled cavity measuring 36 × 46 
mm in the left upper lobe. CT also showed hilar 
calcified lymph nodes. CXR discovered further 
resolution in comparison with that previous one 
on admission (Fig. 2). After culture conversion 
(no positive results of cultures) and extension 
of ATT to 9 months, the patient was discharged 
with a close follow-up in a  respiratory clinic. 
Thus, the positive AFB smear in the 6th month 
of ATT was considered a nonviable strain due to 
the negative culture. 
Discussion
The association between silicosis and TB 
has been well established. Recent findings show 
that an exposure to silica in patients without sil-
icosis may predispose to TB [2]. That risk seems 
to be lifelong even if exposure ceases. Moreover, 
the frequency of TB was 3 to 4 times higher 
in those patients with heavy and longer than 
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Figure 2.	Partial	resolution	of	consolidation	and	pleural	effusion	after	
6	months	of	ATT
15 years exposure. This relationship was con-
firmed in a large prospective cohort study of 1153 
gold miners with and without silicosis [3]. The 
relative risk of TB was 2.8 (95% CI, 1.9–4.1) in 
silicotic men. That risk was elevated to the same 
extent for extrapulmonary TB.
The mechanisms underlying that association 
are not clear. It was suggested that inhaled silica 
modifies the immune reponse of the lung, impairs 
the macrophages function and causes their apop-
tosis. This finding can be confirmed by the obser-
vation that heavier exposure may result in higher 
TB incidence [3]. In addition, surfactant protein 
A is elevated in the bronchoalveolar lavage (BAL) 
fluid of silicotic patients. Its excess seems to be 
linked with increased TB risk [3]. Finally, the TB 
bacilli can remain dormant for a long time within 
the silicotic nodules [3]. Direct impairment of 
macrophages and poor drug penetration into these 
nodules can be responsible for a subsequent treat-
ment failure and high relapse rate in these patients. 
Of note, silicosis and previous TB treatment 
are also the recognized risk factors for non-tuber-
culous mycobacteria (NTM) infections (the mean 
odds ratio (OR) 12.6 and 3.6, respectively [4]. 
Mycobacterium kansasii is found to be the most 
prevalent species. 
In a study of agate stone workers in India, OR 
for an association between silicosis and TB was 
2.75 [5]. Moreover, the latter was a significant 
contributor to mortality. Likewise, the risk of TB 
was elevated nearly three times in silicotic gold 
miners in comparison with the subjects with no 
radiographic evidence of silicosis [3]. In patients 
with no silicosis, the TB risk was found to be 
directly related to the cumulative degree of ex-
posure. The diagnosis was made on average 7.6 
years after the end of exposure. This indicates that 
after the removal of silica source and regardless of 
silicosis, this population is still at a lifelong risk of 
TB. The large exposure to crystalline silica is also 
a major factor in extraordinary TB incidence in 
one of the regions of Portugal [6]. Likewise, silica 
exposure was prevalent among TB patients (OR: 
3.39, 95% CI, 2.6–4.3) [2]. The incidence of TB 
was higher among patients with long exposure (> 
15 years), advanced age, lower level of education, 
male gender and smoking. 
One of the risk factors for TB among silico-
tic patients is smoking (adjusted hazard factor 
1.96, 95% CI, 1.1–3.3) [7]. It increases both risk 
of latent TB infection and later progression to 
the disease. Also, there was observed a  clear 
dose-response relationship between the number 
of cigarettes smoked a day and a number of active 
TB cases. On the other hand, cigarette pack-year 
was a weak risk factor for the development of TB 
[8]. Significant risk factors for TB among silicotic 
patients were as follows: lack of anti-tuberculous 
treatment (ATT) prior to silicosis diagnosis, pro-
gressive massive fibrosis (PMF), small opacities 
exceeding 1.5 mm and caisson work [8]. The 
combination of PMF and an absence of ATT be-
fore silicosis identified the group with the highest 
TB risk. 
There is evidence that TB may affect negative-
ly the clinical course of simple pneumoconiosis. 
In a prospective observation, TB was found to be 
a main risk factor for premature death (relative risk 
(RR) 2.0, p < 0.01) and the development of progres-
sive massive fibrosis (RR 7.0, p < 0.01)[9]. It was 
also found that there was a signicantly elevated 
mortality due to TB among silica exposed workers 
(whetstone cutters) [10]. In that large analysis, in 
the cause of death of 99 cases among cohort of 200 
males from 1955 to 1995, there were 10 TB cases 
(of which 9 cases had silicosis). In contrast, in the 
United States, there was a decline in silicosis-re-
spiratory TB mortality (from 239 per year during 
1968–1972 to 1.2 per year during 2002–2006) [11]. 
This drop probably reflects both prevention and 
better control measures of both diseases. 
The diagnosis of active TB superimposed 
on silicosis can be clinically challenging. The 
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principal imaging findings consistent with TB are 
thick-walled cavities, consolidations, tree-in-bud 
pattern, nodular image asymmetry and rapid dis-
ease progression [12]. Of these, cavitation is the 
strongest indicator of likely silicotuberculosis. In 
a patient with a suggestive occupation history, it is 
reasonable to evaluate old serial X-rays to search 
for any progression of the disease. Since both dis-
eases have a similar mode of presentation, there is 
a chance of their concurrent existence. However, 
the silica exposure may alter the radiological 
resolution of miliary TB. As a consequence, there 
can be more pronounced fibrotic response to TB 
in silicotic patients, which leads to a delayed and 
less complete improvement of milliary TB [13]. 
Of note, there is evidence of long-term respiratory 
consequences of treated TB in silica-dust exposed 
males. In South African miners, TB was associ-
ated with a decline in pulmonary function tests 
(a drop of 40 ml/year in forced expiratory volume 
in 1 second (FEV1) and 43 ml/year in forced vital 
capacity (FVC) [14]. In addition, TB cases had 
more than double chances of breathlessness at 
follow-up. This loss of lung function was greater 
among those with more severe respiratory symp-
toms and later clinical presentation of TB. 
According to World Health Organization 
(WHO) guidelines, patients with silicosis should 
be screened with interferon-gamma release assays 
(IGRA) or tuberculin skin test for latent tuber-
culosis infection (LTBI) [15]. Both testing and 
preventive treatment of silicosis patients with 
LTBI are recommended in high- or middle-income 
countries with a  low TB incidence. The rifam-
picin or isoniazid monotherapy with the least 
hepatotoxity might be the first choice in the pre-
ventive therapy. The other treatment option might 
be combined isoniazid and rifampicin regimen. 
Of interest, tuberculin-positive patients with sil-
icosis have a 30 times higher risk of developing 
TB [11]. However, there is some doubt concerning 
the benefit of IGRA in the clinical management 
of patients with silicosis. There is evidence of 
persistent of interferon-gamma response among 
German miners with no recent TB exposure [16]. 
The predictors of positive IGRA results were 
age > 80 years, foreign place of birth and radio-
logically healed prior TB but not silicosis, and 
smoking. No active TB case during a follow-up 
was detected. Hence, the clinical value of current 
IGRAs among patients exposed to silica remains 
uncertain. That doubt is related to the limited ef-
ficacy of preventive treatment in patients with TB 
and silicosis as well as the risk of drug-induced 
hepatitis. In a double-blind randomized study, the 
different regimens of chemoprophylaxis in sili-
cotic patients reduced TB development, though 
the proportion of active TB cases remained sub-
stantial [17]. On the other hand, a comprehensive 
approach is required to prevent silica associated 
diseases, including better dust exposure control. 
The clinical management of these diseases should 
be consistent with a Global Elimination of Sili-
cosis Campaign organized by the International 
Labour Organization (ILO) and WHO [18].
In conclusion, patients with a  history of 
exposure to silica or silicosis need a regular and 
long-term surveillance as the TB risk in this 
group is significantly elevated — even threefold. 
The risk is found to be lifelong even if exposure 
ceases. Like in our patient, any typical of TB but 
not specific features in the silicotic subject such 
as persistent cough, weight loss, fever should be 
thoroughly examined to exclude TB. In addition, 
any radiological findings such as asymmetric 
nodules, rapid progression or cavitation should 
raise concern. Treatment of TB in these patients 
may be extended as sputum samples may remain 
longer smear-positive . Finally, both silicosis and 
silicotuberculosis patients should be under close 
and regular follow-up in order to detect early any 
new TB case or relapse. 
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